Payment overview · 2025
General Payments
$20.91
1 reported records · 1 companies
Healthcare provider profile · identity verified
Mansoor Ali, MD
Allopathic & Osteopathic Physicians|Hospitalist · CHICAGO, IL · NPI 1760944763
Verified facts
What the public records show
CMS Open Payments records show Mansoor Ali, MD received $20.91 in general payments during 2025 across 1 reported records.
Abbott Laboratories accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Abbott Laboratories | Unresolved — no canonical attribution shown | $20.91 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $20.91 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| FREESTYLE LIBRE 3 Normalized: freestyle libre 3 |
Device | Abbott Laboratories | $20.91 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 553 | 102 |
| Levothyroxine Sodium | Levothyroxine Sodium | 341 | 66 |
| Gabapentin | Gabapentin | 297 | 52 |
| Amlodipine Besylate | Amlodipine Besylate | 274 | 60 |
| Eliquis | Apixaban | 268 | 41 |
| Furosemide | Furosemide | 263 | 59 |
| Lisinopril | Lisinopril | 233 | 44 |
| Escitalopram Oxalate | Escitalopram Oxalate | 217 | 32 |
| Tamsulosin Hcl | Tamsulosin Hcl | 215 | 38 |
| Metoprolol Tartrate | Metoprolol Tartrate | 213 | 39 |
| Mirtazapine | Mirtazapine | 212 | 36 |
| Quetiapine Fumarate | Quetiapine Fumarate | 206 | 29 |
| Potassium Chloride | Potassium Chloride | 195 | 32 |
| Metoprolol Succinate | Metoprolol Succinate | 181 | 45 |
| Pantoprazole Sodium | Pantoprazole Sodium | 181 | 34 |
| Donepezil Hcl | Donepezil Hcl | 171 | 22 |
| Losartan Potassium | Losartan Potassium | 166 | 44 |
| Carvedilol | Carvedilol | 142 | 38 |
| Omeprazole | Omeprazole | 120 | 37 |
| Trazodone Hcl | Trazodone Hcl | 115 | 24 |
| Memantine Hcl | Memantine Hcl | 110 | 17 |
| Sertraline Hcl | Sertraline Hcl | 109 | 23 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 108 | 20 |
| Metformin Hcl | Metformin Hcl | 100 | 23 |
| Warfarin Sodium | Warfarin Sodium | 97 | 12 |
| Clopidogrel | Clopidogrel Bisulfate | 96 | 19 |
| Spironolactone | Spironolactone | 89 | 20 |
| Prednisone | Prednisone | 88 | 21 |
| Simvastatin | Simvastatin | 88 | 17 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 85 | 13 |
| Hydralazine Hcl | Hydralazine Hcl | 79 | 24 |
| Hydrochlorothiazide | Hydrochlorothiazide | 77 | 14 |
| Baclofen | Baclofen | 75 | 15 |
| Famotidine | Famotidine | 75 | 20 |
| Ondansetron Hcl | Ondansetron Hcl | 75 | 26 |
| Finasteride | Finasteride | 73 | 18 |
| Allopurinol | Allopurinol | 67 | 12 |
| Alendronate Sodium | Alendronate Sodium | 59 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 54 | 14 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 54 | 23 |
| Propranolol Hcl | Propranolol Hcl | 54 | suppressed |
| Acyclovir | Acyclovir | 53 | suppressed |
| Latanoprost | Latanoprost | 53 | 15 |
| Bumetanide | Bumetanide | 52 | suppressed |
| Nifedipine Er | Nifedipine | 50 | suppressed |
| Xarelto | Rivaroxaban | 49 | suppressed |
| Bupropion Xl | Bupropion Hcl | 48 | suppressed |
| Hydrocortisone | Hydrocortisone | 48 | suppressed |
| Levetiracetam | Levetiracetam | 48 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 47 | 14 |
| Pravastatin Sodium | Pravastatin Sodium | 46 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 45 | 23 |
| Enulose | Lactulose | 45 | 15 |
| Fluticasone Propionate | Fluticasone Propionate | 45 | 28 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 44 | 13 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 43 | suppressed |
| Amoxicillin | Amoxicillin | 42 | suppressed |
| Methadone Hcl | Methadone Hcl | 42 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 41 | 11 |
| Morphine Sulfate Er | Morphine Sulfate | 41 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 41 | 27 |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 40 | 13 |
| Divalproex Sodium | Divalproex Sodium | 40 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 37 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 36 | suppressed |
| Nystatin | Nystatin | 36 | 22 |
| Buspirone Hcl | Buspirone Hcl | 35 | suppressed |
| Olanzapine | Olanzapine | 34 | suppressed |
| Valsartan | Valsartan | 34 | suppressed |
| Alprazolam | Alprazolam | 32 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 32 | suppressed |
| Risperidone | Risperidone | 32 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 32 | suppressed |
| Celecoxib | Celecoxib | 31 | 12 |
| Doxycycline Hyclate | Doxycycline Hyclate | 31 | 13 |
| Tizanidine Hcl | Tizanidine Hcl | 31 | suppressed |
| Lorazepam | Lorazepam | 30 | suppressed |
| Primidone | Primidone | 30 | suppressed |
| Jardiance | Empagliflozin | 29 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 29 | 16 |
| Aripiprazole | Aripiprazole | 28 | suppressed |
| Cephalexin | Cephalexin | 28 | 13 |
| Fenofibrate | Fenofibrate Nanocrystallized | 28 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 28 | suppressed |
| Levofloxacin | Levofloxacin | 28 | 19 |
| Glimepiride | Glimepiride | 27 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 27 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 26 | 18 |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 26 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 26 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 26 | suppressed |
| Lubiprostone | Lubiprostone | 26 | suppressed |
| Calcitriol | Calcitriol | 25 | suppressed |
| Digoxin | Digoxin | 25 | suppressed |
| Meloxicam | Meloxicam | 25 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 24 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 24 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 23 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 23 | suppressed |
| Methotrexate | Methotrexate Sodium | 23 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 22 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 22 | suppressed |
| Haloperidol Lactate | Haloperidol Lactate | 21 | suppressed |
| Methylprednisolone | Methylprednisolone | 21 | suppressed |
| Pilocarpine Hcl | Pilocarpine Hcl | 21 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 21 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 20 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 20 | suppressed |
| Januvia | Sitagliptin Phosphate | 20 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 19 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 19 | suppressed |
| Pregabalin | Pregabalin | 19 | suppressed |
| Xifaxan | Rifaximin | 19 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 18 | suppressed |
| Ingrezza | Valbenazine Tosylate | 18 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 17 | suppressed |
| Ezetimibe | Ezetimibe | 17 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 17 | 12 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 17 | suppressed |
| Azithromycin | Azithromycin | 16 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 16 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 16 | 12 |
| Myrbetriq | Mirabegron | 16 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 16 | 16 |
| Topiramate | Topiramate | 16 | suppressed |
| Trulicity | Dulaglutide | 16 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 15 | suppressed |
| Lithium Carbonate Er | Lithium Carbonate | 15 | suppressed |
| Clonazepam | Clonazepam | 14 | suppressed |
| Dicloxacillin Sodium | Dicloxacillin Sodium | 14 | suppressed |
| Galantamine Hbr | Galantamine Hbr | 14 | suppressed |
| Gemfibrozil | Gemfibrozil | 14 | suppressed |
| Imipramine Hcl | Imipramine Hcl | 14 | suppressed |
| Lactulose | Lactulose | 14 | suppressed |
| Lansoprazole | Lansoprazole | 14 | suppressed |
| Ozempic | Semaglutide | 14 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 13 | suppressed |
| Fosinopril Sodium | Fosinopril Sodium | 13 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 13 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 13 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 12 | suppressed |
| Glipizide | Glipizide | 12 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 12 | suppressed |
| Amantadine | Amantadine Hcl | 11 | suppressed |
| Cefpodoxime Proxetil | Cefpodoxime Proxetil | 11 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 11 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 11 | suppressed |
| Donepezil Hcl Odt | Donepezil Hcl | 11 | suppressed |
| Entacapone | Entacapone | 11 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 11 | suppressed |
| Folic Acid | Folic Acid | 11 | suppressed |
| Lovastatin | Lovastatin | 11 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 11 | suppressed |
| Scopolamine | Scopolamine | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $20.91 · 1 records | Abbott Laboratories | FREESTYLE LIBRE 3 | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error